International

ISO/TR 24971:2020 Medical Devices: Guidance on the Application of ISO 14971

144 controls. 0 other frameworks in our corpus share controls with it. Here is all of it, and how much of it you are already doing.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

144 controls 0 frameworks share controls with it International verified against its source document

Every control below is one this framework asks for. The right hand column counts how many other frameworks in our corpus carry the same control, which is the difference between doing this work once and doing it again for the next standard.

There is no implementation kit for this framework yet. The control list and the overlap above are free and complete.

What you already have

Frameworks whose controls overlap this one, most first. If you run any of them, the count is roughly what you have already evidenced.

No measured overlap with another framework in the corpus.

Every control

CodeControlAlso in
10.1General production and post-production monitoring0
10.2Sources of production and post-production information0
10.3Reviewing collected information for safety relevance0
10.4Actions following information review0
4.1Ongoing risk management process across life cycle0
4.2.1Top management commitment to risk management0
4.2.2Policy for risk acceptability criteria0
4.2.3Review of risk management process suitability0
4.3Competence of risk management personnel0
4.4.1Content and upkeep of the risk management plan0
4.4.2Scope of the risk management plan0
4.4.3Assignment of responsibilities and authorities0
4.4.4Planning reviews of risk management activities0
4.4.5Criteria for risk acceptability in the plan0
4.4.6Method and criteria for overall residual risk0
4.4.7Planning verification of risk control measures0
4.4.8Collecting and reviewing production and post-production information0
4.5Risk management file and traceability0
5.1Risk analysis process steps0
5.2Intended use and foreseeable misuse0
5.3Characteristics affecting safety0
5.4.1Hazards and their origins0
5.4.2Hazardous situations in normal condition0
5.4.3Hazardous situations from faults0
5.4.4Random faults and their causes0
5.4.5Systematic faults and prevention0
5.4.6Security vulnerabilities and their effects0
5.4.7Event sequences and combinations0
5.5.1Estimating risk in general0
5.5.2Probability estimation and levels0
5.5.3Risks where probability is unknown0
5.5.4Severity levels and descriptors0
5.5.5Risk matrix examples and selection0
6Comparing estimated risks with acceptability criteria0
7.1.1Priority order for medical device design risk control0
7.1.2Risk control for manufacturing and outsourced processes0
7.1.3Using standards as risk control evidence0
7.2Verifying implementation and effectiveness of controls0
7.3Evaluating residual risk after controls0
7.4.1When benefit-risk analysis applies0
7.4.2Estimating the expected clinical benefit0
7.4.3Criteria applied to benefit-risk judgements0
7.4.4Weighing benefit against residual risk0
7.4.5Worked examples of benefit-risk conclusions0
7.5Reviewing risks created by risk control measures0
7.6Confirming completeness of risk control0
8.1Evaluating overall residual risk0
8.2Inputs to the overall evaluation0
8.3Approaches to evaluating overall residual risk0
9Risk management review0
A.1Purpose of the hazard identification questions0
A.2.1Intended use and manner of use0
A.2.10Modification of the patient environment0
A.2.11Measurements and their reliability0
A.2.12Interpretive output and algorithms0
A.2.13Use with other devices, medicines or technologies0
A.2.14Unwanted energy and substance outputs0
A.2.15Susceptibility to environmental influences0
A.2.16Effects of the device on its environment0
A.2.17Consumables and accessories0
A.2.18Maintenance and calibration0
A.2.19Software installation and updates0
A.2.2Implanted devices and in-body lifetime0
A.2.20Access to information through physical ports0
A.2.21Storage of data important to patient care0
A.2.22Restricted shelf life0
A.2.23Delayed and cumulative use effects0
A.2.24Mechanical forces on the device0
A.2.25What limits the device lifetime0
A.2.26Single-use devices0
A.2.27Decommissioning, disposal and data removal0
A.2.28Training and skills needed to install or use0
A.2.29How safety information reaches users0
A.2.3Contact with patients or other persons0
A.2.30New or changed manufacturing processes0
A.2.31Dependence on usability of the user interface0
A.2.32Alarm systems0
A.2.33Foreseeable misuse0
A.2.34Mobile and portable devices0
A.2.35Dependence on essential performance0
A.2.36Devices with a degree of autonomy0
A.2.37Output feeding a clinical decision0
A.2.4Materials and components in use0
A.2.5Energy delivered to or taken from the patient0
A.2.6Substances delivered to or drawn from the patient0
A.2.7Processing of biological material for reuse0
A.2.8Sterility and microbiological control0
A.2.9Routine cleaning and disinfection by the user0
B.1Techniques that support risk analysis0
B.2Preliminary hazard analysis early in development0
B.3Fault tree analysis from a top event0
B.4Event tree analysis of incident sequences0
B.5Failure mode and effects analysis by component0
B.6Hazard and operability study with guide words0
B.7Hazard analysis and critical control points0
C.1Policy, criteria, control and evaluation0
C.2Policy for criteria on risk acceptability0
C.3Setting criteria for risk acceptability0
C.4Practicability and residual risk magnitude0
C.5Residual risk compared against criteria0
C.6Examples of policy, criteria and evaluation links0
Clause-1Scope of the guidance0
Clause-IntroductionAim and layout of the guidance0
D.1Difference between safety information and residual risk disclosure0
D.2Using information for safety as a control0
D.3Disclosing significant residual risks to users0
E.1Role of consensus standards in risk management0
E.2Using product safety standards in risk management0
E.3Aligning process standards with ISO 149710
F.1Security risks within the risk management process0
F.2Security terminology mapped to ISO 149710
F.3Harm scope and security related risks0
F.4How security risk management works0
F.5Ranking confidentiality, integrity and availability0
G.1Using existing information to build a risk management file0
G.2Planning remaining risk management activities0
G.3Building the initial risk management file0
H.1.1Applying ISO 14971 to IVD devices0
H.1.2Accounting for intermediaries and laboratory risk management0
H.2.1Intended use and reasonably foreseeable misuse0
H.2.2Characteristics related to patient safety0
H.2.3Known and foreseeable hazards to patients0
H.2.4Identifying and classifying potential harms0
H.2.5Defining hazardous situations for IVD risk analysis0
H.2.6Describing foreseeable sequences of events0
H.2.7Estimating the combined probability of harm0
H.3.1Focusing risk control on manufacturer influence0
H.3.2Designing for accurate and reliable results0
H.3.3Adding detection features to device and process0
H.3.4Providing effective information for safety0
H.3.5Standards as evidence for risk control0
H.3.6Training and educating device users0
H.4Weighing benefit against risk0
H.5.1Disclosing residual risks to users0
H.5.2Spelling out performance specifications0
H.5.3Disclosing device limitations0
H.5.4Deciding on generally known limitations0
H.6.1Setting up monitoring after production0
H.6.2Monitoring analytical performance data0
H.6.3Monitoring clinical performance and harms0
H.7.1Introduction to IVD risk scenarios0
H.7.2Worked example for laboratory analyser0
H.7.3Worked example for self-testing glucose device0
H.7.4Worked example for point-of-care delay0

Tell me when ISO/TR 24971:2020 Medical Devices: Guidance on the Application of ISO 14971 files something new

One email when a public company newly discloses something this framework governs, naming the company and what our corpus says it puts in scope. Nothing else, and one click to stop.

What this page is

A control-level reference for ISO/TR 24971:2020 Medical Devices: Guidance on the Application of ISO 14971, drawn from our framework corpus. Control codes and titles are references to the standard, not reproductions of it. The overlap counts and the auditor artefacts are our own work and are the part you will not find elsewhere.

Measure this against what you already run · All frameworks · Today's edition